Hypercalcemia and gallium nitrate.
Gucalp
Rasim
R
Department of Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York, USA.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D016207:Cytokines / Q000378:metabolism; D004164:Diphosphonates / Q000627:therapeutic use; D005708:Gallium / Q000627:therapeutic use*; D006728:Hormones / Q000378:metabolism; D006801:Humans; D006934:Hypercalcemia / Q000188:drug therapy* / Q000209:etiology; D007093:Imidazoles / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D009369:Neoplasms / Q000150:complications*; D000077268:Pamidronate; D016032:Randomized Controlled Trials as Topic; D000077211:Zoledronic Acid
D000970:Antineoplastic Agents; D050071:Bone Density Conservation Agents; D016207:Cytokines; D004164:Diphosphonates; D006728:Hormones; D007093:Imidazoles; D000077211:Zoledronic Acid; D005708:Gallium; D000077268:Pamidronate; C027235:gallium nitrate